A R T I C L E S
Nicolaou et al.
Conclusion
ratio. It is noteworthy that attempted asymmetric epoxidation
of olefin 125 with the commercially available Jacobsen-Katsuki
catalyst 12729 led to low epoxide yields and poor diastereose-
lectivity in a reaction that was accompanied by significant
aromatization to the quinoline ring system. NBS-induced
bromination of epoxide 128 in the presence of AIBN (cat.)
allowed the formation of bromide 129 (diastereomeric mixture,
44% combined yield, plus 29% recovered starting material 128),
exposure of which to DBU at ambient temperature led to allylic
epoxide 130 in 96% yield. Epoxide 130 was then opened
regioselectively and, as expected, stereospecifically30 by the
amino group of L-isoleucine allyl ester 131 in the presence of
LiClO4 in acetonitrile at 60 °C to afford amino alcohol 132 in
69% yield. Treatment of this substance (132) with TBSOTf in
the presence of i-Pr2NEt then furnished bis-TBS derivative 133
in 94% yield. The methyl ester of 133 was then selectively
hydrolyzed by the action of NaOH in H2O:MeOH:THF (1:1:
1.2), leading to carboxylic acid 134 in 89% yield. The
9-fluorenylmethyl (Fm) group was then installed onto the newly
generated carboxyl moiety through a Yamaguchi-type31 esteri-
fication reaction (2,4,6-trichlorobenzoyl chloride, Et3N; then
FmOH, 4-DMAP, 64% yield), leading to diester 135, from
which the allyl group was cleaved using the n-Bu3SnH-PdCl2-
(PPh3)2 (cat.) method32 to give carboxylic acid 136 in quantita-
tive yield. Finally, coupling of carboxylic acid 136 with
dipeptide 116, as facilitated by HATU and HOAt, led to
conjugate 137 in 85% yield. The allyl ester of 137 was then
selectively cleaved employing the n-Bu3SnH-PdCl2(PPh3)2
(cat.) protocol,32 furnishing the targeted quinaldic acid key
building block 24 in quantitative yield.
Described herein is the chemistry that provided the foundation
for the eventual total synthesis of thiostrepton (1). Thus, efficient
synthetic routes to all required key building blocks (23, 24, 26,
28, and 29) are detailed. Of particular interest was the evolution
of the synthetic scheme toward the dehydropiperidine core of
the molecule. Thus, inspired by the proposed biosynthesis of
1, the described campaign to synthesize the dehydropiperidine
core 28 began with a hetero-Diels-Alder dimerization reaction
of azadiene system 30, but was met immediately with a
problem: the formed adduct suffered rapid aza-Mannich rear-
rangement to a bridged bicyclic system (49 + 49′). This problem
was solved by adding benzylamine to the reaction mixture,
which caused imine exchange, liberating the free amine before
the destructive rearrangement, and led predominantly to the
desired dehydropiperidine product 28 (+28′). This product (28,
5R,6S) was, however, formed as an inseparable 1:1 mixture with
its diastereomer (28′, 5S,6R). The trans relationship of the two
thiazoles on the imine ring was proven by NMR spectroscopy
and X-ray crystallographic analysis of a derivative (51) of the
aza-Mannich rearrangement product, but the relative stereo-
chemistry between the core centers and those across from the
thiazole ring could not be defined within each isomer due to
the lack of single compounds at this stage. In an effort to grow
the peptide chain upon the primary amino group, and in the
hope that the new derivatives would be chromatographically
separable, the Diels-Alder mixture of products (28 + 28′) was
then coupled with N-Alloc alanine. Indeed, not only were the
two formed diastereomers 57 and 57′ separable by silica gel
chromatography, but also a derivative of one of them crystallized
with one molecule of L-tataric acid. The X-ray crystallographic
analysis of this salt (58), while solving the relative stereochem-
istry problem, revealed another: a rearrangement of the amino-
imine from the desired six-membered ring to a dead-end, five-
membered amino-imine system. This newly arisen obstacle was
overcome upon a systematic exploration of a series of alanine
equivalents and coupling conditions, eventually leading to a
coupling procedure that suffered no rearrangement and which
furnished the desired alanine-bound dehydropiperidine core (70)
of thiostrepton. The problem of determining the relative
stereochemistry within this core, however, resurfaced since no
crystalline derivatives were in sight. This thorny problem was
solved by converting one of the coupled products (70) to a
degradation product (74) obtained from natural thiostrepton. It
is worth noting that, besides overcoming the initial hurdles
toward the dehydropiperidine core of thiostrepton, these inves-
tigations provided a wealth of novel skeleta for molecular
diversity construction relevant to chemical biology and medici-
nal chemistry studies.
Attempted selective deprotection of the Fm-protected carboxyl
end of 137 under basic conditions (e.g. Et2NH) led to partial
elimination of its phenylseleno group, resulting in a mixture of
products. However, treatment of this compound (137) with
excess t-BuOOH effected selective selenium oxidation and
spontaneous elimination of the resulting selenoxide to afford
dehydroalanine derivative 138 in 82% yield. The Fm group
could then be removed from the latter intermediate (138) by
the action of Et2NH, generating carboxylic acid 139 in 60%
yield. Alternatively, the same diester derivative 138 could be
converted to the regioisomeric carboxylic acid 140 by the action
of n-Bu3SnH in the presence of catalytic amounts of PdCl2-
(PPh3)2 in quantitative yield. These results proved useful to us
as we contemplated how to proceed over the treacherous ground
that surely would lie ahead.
(28) (a) Ito, K.; Yoshitake, M.; Katsuki, T. Tetrahedron 1996, 52, 3905-3920.
(b) Sasaki, H.; Irie, R.; Hamada, T.; Suzuki, K.; Katsuki, T. Tetrahedron
1994, 50, 11827-11838. (c) For a pertinent review in this area, see:
Katsuki, T. Curr. Org. Chem. 2001, 5, 663-678.
(29) (a) Jacobsen, E.; Zhang, W.; Muci, A. R.; Ecker, J. R.; Deng, L. J. Am.
Chem. Soc. 1991, 113, 7063-7064. (b) Irie, R.; Noda, K.; Ito, Y.;
Matsumoto, N.; Katsuki, T. Tetrahedron Lett. 1990, 31, 7345-7348.
(30) (a) Boyd, D. R.; Davies, R. J. H.; Hamilton, L.; McCullough, J. J.; Malone,
J. F.; Porter, H. P.; Smith, A. J. Org. Chem. 1994, 59, 984-990. (b)
Bushman, D. R.; Sayer, J. M.; Boyd, D. R.; Jerina, D. M. J. Am. Chem.
Soc. 1989, 111, 2688-2691.
(31) (a) Inanaga, J.; Hirata, K.; Saeki, H.; Katsuki, T.; Yamaguchi, M. Bull.
Chem. Soc. Jpn. 1979, 52, 1989-1993. (b) Nicolaou, K. C.; Patron, A. P.;
Ajito, K.; Richter, P. K.; Khatuya, H.; Bertinato, P.; Miller, R. A.;
Tomaszewski, M. J. Chem. Eur. J. 1996, 2, 847-868.
(32) (a) de la Torre, B. G.; Torres, J. L.; Bardaj´ı, E.; Clape´s, P.; Xaus, N.; Jorba,
X.; Calvet, S.; Albericio, F.; Valencia, G. J. Chem. Soc., Chem. Commun.
1990, 965-967. (b) For a review on the use and removal of allylic
protecting groups, see: Guibe´, F. Tetrahedron 1998, 54, 2967-3042.
With the successful completion of the extendable dehydro-
piperidine core and the remaining fragments also at hand, we
were then poised for the next phase of the campaign: the
assembly of the synthesized key building blocks and elaboration
of the resulting advanced intermediates to thiostrepton. These
endeavors, accompanied as they were with their own complica-
tions, are described in the following article.10
Acknowledgment. We thank Drs. D. H. Huang, G. Siuzdak,
and R. Chadha for NMR spectroscopic, mass spectrometric, and
X-ray crystallographic assistance, respectively. Financial support
9
11174 J. AM. CHEM. SOC. VOL. 127, NO. 31, 2005